Objective: Adiponectin is a 29-kd adipocyte-secreted protein that has been linked to insulin resistance in obesity and diabetes. The aim of the present study was to evaluate adiponectin levels in the insulinresistant state of diabetes in gestation.
Methods: Term, gravid subjects with diabetes (n = 31; age, 30.0±0.9 years; weight, 98.8±4.6 kg) and healthy, term, gravid subjects (n = 27; age, 26.1±1.1 years; weight, 91.2±3.78 kg) were examined. The diabetes group consisted of 11 class A1, 11 class A2, and nine class B subjects. Plasma insulin, glucose, adiponectin, and leptin were measured on samples obtained immediately before Cesarean or vaginal delivery. Data were presented as means ± SE, and signficance is set at P ≤ .05.
Results: We observed decreased adiponectin levels in class A2 (4.93 ± 0.58,μg/mL; P = .013) and class B diabetics (3.33 ± 0.56,μg/mL; P = .001) as compared to controls (8.17 ± 0.82,μg/mL), while a nonsignficant decrease was also observed in class A 1 (6.58 ± 1. 13,μg/mL; P = .213). When grouping all gravid subjects, we observed that non-Caucasian subjects (n = 42) (5.51 ± 0.51,μg/mL; P - .003) had lower adiponectin levels than Caucasian subjects (n = 16) (8.88 ± 1. 11 ug/mL). Within tIe non-Caucasian group, wefound significantly lower adiponectin levels in diabetic gravid subjects (class A2: 4.24 ± 0.75,μg/mL; P = .044; and class B: 3.33 ± 0.56 μg/mL; P = .005) compared tvith nondiabetic gravid subjects (7.05 ± 0.80 μg/mL).
Conclusion: Class A2 and B gestational diabetes are associated with suppressed levels of adiponectin, similar to thatfound in other insulin-resistant states (type II diabetes and obesity).
1. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes1991;40Suppl 2:18-24.
2.
2. King H. Epidemiology of glucose intolerance and gestational diabetes in women of childbearing age. Diabetes Care1998;21Suppl 2:B9-B13.
3.
3. Ryan EA, Enns L. Role of gestational hormones in the induction of insulin resistance. J Clin Endocrinol Metab1988;67:341-347.
4.
4. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes2002;51:2207-2213.
5.
5. Pittas AG, Joseph NA, Greenberg AS. Adipocytokines and insulin resistance. J Clin Endocrinol Metab2004;89:447-452.
6.
6. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun1999;257:79-83.
7.
7. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol2000;20:1595-1599.
8.
8. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adiposespecific gene dysregulated in obesity. J Biol Chem1996;271: 10697-10703.
9.
9. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipideniia. J Clin Endocrinol Metab2002;87:2764-2769.
10.
10. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: Close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab2001;86: 1930-1935.
11.
11. Yamauchi T, Kamon J, Waki H, et al. Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis. J Biol Chem2003;278:2461-2468.
12.
12. Yamauchi T, Kamon J, Waki H, et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med2001;7:941-946.
13.
13. Fruebis J, Tsao TS, Javorschi S, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci U S A2001;98:2005-2210.
14.
14. Wu X, Motoshima H, Mahadev K, Stalker TJ, Scalia R, Goldstein BJ. Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes. Diabetes2003;52:1355-1363.
15.
15. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med2002;8:1288-1295.
16.
16. Lihn AS, Richelsen B, Pedersen SB, et al. Increased expression of TNF-alpha, IL-6, and IL-8 in HALS: Implications for reduced adiponectin expression and plasma levels. Am J Physiol Endocrinol Metab2003;285:E1072-E1080.
17.
17. Orio F Jr, Palomba S, Cascella T, et al. Adiponectin levels in women with polycystic ovary syndrome. J Clin Endocrinol Metab2003;88:2619-2623.
18.
18. Hulver MW, Saleh 0, MacDonald KG, Pories WJ, Barakat HA. Ethnic differences in adiponectin levels. Metabohsm2004;53:1-3.
19.
19. Ramsay JE, Jamieson N, Greer IA, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension2003;42:891-894.
20.
20. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand2004;83:341-347.
21.
21. Haffner SM, D'Agostino R, Saad MF, et al. Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study. Diabetes1996;45:742-748.
22.
22. Karter AJ, Mayer-Davis EJ, Selby JV, et al. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insuhn Resistance and Atherosclerosis Study. Diabetes1996;45: 1547-1555.
